Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease

O'Hagan S, Galway N, Shields MD, Mallett P, Groves HE

Drug, Healthcare and Patient Safety 2023, 15:103-112

Published Date: 11 September 2023